Download PDFPDF
Congenital sucrase–isomaltase deficiency: diagnostic challenges and response to enzyme replacement therapy
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Re:Invertase is an alternative to Sucraid in the treatment of CSID

    My child also has CSID. She is about to be 8 yrs old and has been on Sucraid for the last 6-7 yrs. I am looking for an alternative to this medication as sometimes we cannot get the medication and have to go a strict diet until we can get some again. I will look into this alternative and post results later.

    Conflict of Interest:

    None declared

    Conflict of Interest:
    None declared.
  • Published on:
    Invertase is an alternative to Sucraid in the treatment of CSID
    • Iain S. Chalmers, Paediatric Gastroenterology Registrar
    • Other Contributors:
      • Ghassan Al-Hourani, and Richard K. Russell

    We read with interest the article by Puntis and Zamvar(1), reporting their experience of children with congenital sucrase-isomaltase deficiency (CSID) including response to enzyme replacement therapy with Sucraid (sucrasidase). We report our own experience of a child with CSID which offers an additional perspective and therapeutic option. Our patient is a girl who was diagnosed with CSID at 8 months of age. She was refer...

    Show More
    Conflict of Interest:
    None declared.